CLINICAL TRIAL

We Test for HIV Infections

Waitlist Available · < 65 · Male · Detroit, MI

This study is evaluating whether different ways of delivering HIV testing and counseling services to young people will lead to more people being tested for HIV.

See full description

About the trial for HIV Infections

Eligible Conditions
Human Immunodeficiency Virus Infection(HIV)/Acquired Immunodeficiency Syndrome (AIDS) · HIV Infections

Treatment Groups

This trial involves 2 different treatments. We Test is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.

Main TreatmentA portion of participants receive this new treatment to see if it outperforms the control.
We Test
BEHAVIORAL
Control TreatmentAnother portion of participants receive the standard treatment to act as a baseline.
IHTC
BEHAVIORAL

Eligibility

This trial is for male patients aged 65 and younger. There are 9 eligibility criteria to participate in this trial as listed below.

Inclusion & Exclusion Checklist
Mark “yes” if the following statements are true for you:
At least one partner must be HIV-negative or status unknown
INDEX PARTNER MUST BE SEXUALLY ACTIVE (ANY ACTIVITY THAT COULD LEAD TO ORGASM)
CURRENTLY SEEING SOMEONE, DATING, EXPERIMENTING WITH RELATIONSHIPS OR IN A RELATIONSHIP
LIVE IN OR NEAR NEW YORK CITY OR DETROIT OR SAN DIEGO
GENDER IDENTITY AS MALE OR nonbinary, GENDERQUEER, agender OR GENDER NONCOMFORMING
THE INDEX PARTNER must be 15-24 years old
YMSM under age 18 MUST HAVE AN AGE CONCORDANT PARTNER TO PARTICIPATE IN THIS STUDY, I.E., MINORS may only participate in the study with a partner within 2 years of age OF THE MINOR SUBJECT'S AGE. THE AGE CONCORDANT PARTNER MUST BE AT LEAST FIFTEEN YEARS OLD.
HAVE HAD SEX, HOOKED UP WITH OR MADE OUT WITH THAT PERSON
Both partners must be able to communicate in English.
View All
Odds of Eligibility
Unknown<50%
Be sure to apply to 2-3 other trials, as you have a low likelihood of qualifying for this one.Apply To This Trial
Similar Trials

Approximate Timelines

Please note that timelines for treatment and screening will vary by patient
Screening: ~3 weeks
Treatment: varies
Reporting: 30 days
Screening: ~3 weeks
Treatment: Varies
Reporting: 30 days
This trial has approximate timelines as follows: 3 weeks for initial screening, variable treatment timelines, and reporting: 30 days.
View detailed reporting requirements
Trial Expert
Connect with the researchersHop on a 15 minute call & ask questions about:
- What options you have available- The pros & cons of this trial
- Whether you're likely to qualify- What the enrollment process looks like

Measurement Requirements

This trial is evaluating whether We Test will improve 2 primary outcomes and 1 secondary outcome in patients with HIV Infections. Measurement will happen over the course of 30 days.

Communication skills
30 DAYS
Interpersonal Communication Competence Scale, higher scores are associated with better communication skills, range 0 - 120
30 DAYS
HIV Transmission Risk Behavior
30 DAYS
Self-reported Condomless anal sex in the absence of PrEP
30 DAYS
Bacterial STI infection in the absence of PrEP
30 DAYS
APTIMA (TMA RNA test) for Urine and Rectal samples
30 DAYS

Who is running the study

Principal Investigator
S. N.
Sylvie Naar, Principal Investigator
Florida State University

Patient Q & A Section

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the latest research for hiv infections?

Current research has led to the development of novel prevention interventions, including antiretroviral therapy (ART) and sperm DNA cryopreservation methods. In the future, these approaches will have the potential to halt and even reverse the human immunodeficiency virus infection.

Anonymous Patient Answer

What are the signs of hiv infections?

HIV infections cause symptoms such as a cough. Signs of HIV infection may also include headaches, feeling tired, skin or pubic lesions, or the appearance of the genitals. Aspects of the brain may be affected such as cognitive dysfunction, mood changes and problems with coordination. These and many other symptoms can make the diagnosis of HIV or AIDS difficult. However, many symptoms are nonspecific and can be caused by many other factors such as malaria, typhoid, or chicken pox. A medical history is very important to establish a complete picture. However, in developing countries such as South Africa, the HIV test is not available for everyone, so this can make it difficult to make an accurate diagnosis.

Anonymous Patient Answer

What causes hiv infections?

While human immunodeficiency virus (HIV) is typically transmitted through unprotected sex and shared needles, HIV may also be transmitted by contact with bodily fluid and/or bodily secretions from an infected person. Most blood-borne infections of HIV also have a risk of other diseases. HIV is transmitted through many types of semen, blood, urine, breast milk and certain kinds of feces. In addition to HIV, blood-borne infections that may cause disease in the body include malaria, babesiosis, lymphatic filariasis and Leishmaniasis. Other blood-borne infections that may cause disease or illnesses in the body include hepatitis A, hepatitis B, hepatitis C, and Human T-lymphotropic virus (HTLV) infections.

Anonymous Patient Answer

What is hiv infections?

HIV is a disease that is caused by a virus that is transmitted through sexual sex partners or through contact with infected blood or body fluids. It is among the first diseases that spread through human contact. HIV can be diagnosed during any stage of the disease. It is also treatable throughout the full length if the disease and is a lifelong health problem, but can be prevented if those infected find out and prevent themselves from getting infected.\n

Anonymous Patient Answer

Can hiv infections be cured?

Hiv infections cannot be cured. This is the first study to show that symptomatic HIV-2 infection is manageable with current treatment regimens. These data challenge the assumption that symptomatic HIV-2 infection is invariably indicative of an oncogenic HIV-2 clone.

Anonymous Patient Answer

How many people get hiv infections a year in the United States?

About 43,000 new HIV infections will occur in the U.S. in 2006. Overall, between one-quarter and one-half of new HIV infections are in men aged 14–24 years old. In 2005, about 26,000 new diagnoses of HIV infections (approximately 7 per 100,000 people) occurred among women of childbearing age ages 15–24 years old. In addition, 1 in 2 new HIV infections among people aged 14–21 years old occurs in a young white male. In July 2010, approximately 40,000 new hiv diagnoses were reported in the Unites States.

Anonymous Patient Answer

What are common treatments for hiv infections?

All forms of therapy for HIV infection are common. All of the methods are noninvasive, and most have a significant chance of success with appropriate therapy. The most common treatment for HIV-positive patients is HAART. The HAART method includes a combination of antiretroviral drugs and HIV-suppressive therapy. Most patients with HIV and AIDS do well and remain stable in remission.

Anonymous Patient Answer

What is the average age someone gets hiv infections?

Using CDC data, we found that, while on average heterosexual couples tend to get hiv on average 20 years younger than non-homosexual couples (35 years for homosexuals vs 37 years for heterosexuals), the proportion of younger men with hiv in every city in our sample ranged from 32% (New York City) to 63% (San Francisco). [With the help of Power.

Anonymous Patient Answer

Has we test proven to be more effective than a placebo?

Treatment of patients with HAART during the time between routine HCV testing is recommended by the British Thoracic Society Guidelines. We tested the effect of HCV testing from routine testing to only treat symptomatic patients, but found no evidence of improved prognosis for HCV-infected patients with good sustained viral suppression. Patients without an indication for antiviral treatment had a worse outcome with HCV screening, and patients without an indication for treatment had more adverse events. It is the time for a systematic review of HCV testing in HIV-infected patients.

Anonymous Patient Answer

Who should consider clinical trials for hiv infections?

Those considering clinical trials need to consider the type of trial they want to join and their baseline characteristics. Only a small number of clinicians thought that all patients should be considered for clinical trials.

Anonymous Patient Answer

How serious can hiv infections be?

Most symptomatic HIV-related infections do not present to the emergency room because patients are more likely to seek treatment elsewhere (i.e., to the emergency department). In addition, HIV can be asymptomatic for years if treated adequately. In fact, people with no symptoms of infections may be diagnosed with HIV/AIDS, despite not using regular, appropriate personal protection. Thus, HIV can present itself in such a wide variety of ways.\n\nThe differential diagnosis for patients with a fever may be considerable, and the management of patients with fevers requires a good knowledge of how to deal with them.

Anonymous Patient Answer

Does hiv infections run in families?

In this population, a large familial clustering of HIV infection was found. However, only weak correlation (r = 0.12) between genetic susceptibility and family history of HIV infection could be seen. The prevalence of HIV infection in relatives of people with HIV infection was low, but family clustering can not be excluded. Interestingly, the probability of finding some degree of genetic susceptibility in close relatives of people with HIV infection was not higher than in the general population.

Anonymous Patient Answer
See if you qualify for this trial
Get access to this novel treatment for HIV Infections by sharing your contact details with the study coordinator.